Viewing Study NCT03414450

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2026-01-22 @ 4:07 PM
Study NCT ID: NCT03414450
Status: WITHDRAWN
Last Update Posted: 2018-10-25
First Post: 2018-01-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies
Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) View
None Ph- Acute Lymphoblastic Leukemia (Ph-ALL) View
None Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) View
None Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mnk kinase inhibitor, Mnk kinase View